Compare the role of positron emission tomography scan to conventional imaging in the evaluation of advanced head and neck cancers
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20174335Keywords:
Head and neck cancer, Positron emission tomography scan, ImagingAbstract
Background: Advanced stages of head and neck cancers need careful evaluation by imaging to rule out multiple nodal and distant metastasis which might influence management and prognosis. The aim of the study was to compare the role of PETCT scan to MRI in the initial evaluation in advanced cancers of head and neck.
Methods: The study included 46 patients having advanced stages of head and neck squamous cancers. The patients underwent clinical examination, endoscopy, an initial CT/MRI of the disease site and conventional metastatic workup with an X-ray Chest and USG abdomen. The patients then underwent PET/CT. Tumor restaging was done after the PETCT and the results of CT/ MRI to PETCT were compared.
Results: There was upstaging of disease in patients with identification of multiple/ bilateral nodes and distant metastasis following PETCT.
Conclusions:PETCT scan has an impact on the initial upstaging staging of disease compared to conventional imaging.
Metrics
References
Kim SY, Roh J-L, Yeo N-K, Kim JS, Lee JH, Choi S-H, et al. Combined 18F fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol. 2007;18(10):1698–703.
Branstetter BF, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, et al. Head and Neck Malignancy: Is PET/CT More Accurate than PET or CT Alone? Radiol. 2005;235(2):580–6.
Schwartz DL, Macapinlac HA, Weber RS. FDG-PET Staging of Head and Neck Cancer—Can Improved Imaging Lead to Improved Treatment? JNCI J Natl Cancer Inst. 2008;100(10):688–9.
Laubenbacher C, Saumweber D, Wagner-Manslau C, Kau RJ, Herz M, Avril N, et al. Comparison of Fluorine-18-Fluorodeoxyglucose PET, MRI and Endoscopy for Staging Head and Neck Squamous-Cell Carcinomas. J Nucl Med. 1995;36(10):1747–57.
Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck. 2001;23(12):1056–60.
Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, et al. 18F-FDG PET/CT for Detecting Nodal Metastases in Patients with Oral Cancer Staged N0 by Clinical Examination and CT/MRI. J Nucl Med. 2006;47(5):755–62.
Ng S-H, Chan S-C, Liao C-T, Chang JT-C, Ko S-F, Wang H-M, et al. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypo-pharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT. Neuroradiol. 2008;50(11):969–79.
